Last 12 months
Inside the activity.
0 purchase rows · 74 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 11 |
| Dec 2025 | 0 | 7 |
| Jan 2026 | 0 | 6 |
| Feb 2026 | 0 | 6 |
| Mar 2026 | 0 | 9 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 5 |
| Aug 2026 | 0 | 9 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 15, 2019 Filed Aug 19, 2019 19:59 UTC |
Brogna SalvatoreEVP & Chief Operating Officer
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $499.87 | $0.00 |
DisclosureSEC source: 0001035267-19-000122 · edgardoc.xml · derivative · entry 1 Brogna Salvatore · CIK 0001519413 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 4,500 shares Expires 2029-08-15 F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. Option shall vest 7/48 one month after the date of grant and 1/48th each month thereafter. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:05 UTC |
MOHR MARSHALLExecutive VP & CFO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 3,500 | $0.00 Strike: $499.87 | $0.00 |
DisclosureSEC source: 0001035267-19-000124 · edgardoc.xml · derivative · entry 1 MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 3,500 shares Expires 2029-08-15 F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. Option shall vest 7/48 one month after the date of grant and 1/48th each month thereafter. Read SEC document |
| August 15, 2019 Filed Aug 19, 2019 20:45 UTC |
GUTHART GARY SDirector · President & CEO
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $499.87 | $0.00 |
DisclosureSEC source: 0001035267-19-000126 · edgardoc.xml · derivative · entry 1 GUTHART GARY S · CIK 0001280628 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2029-08-15 F1 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. Option shall vest 7/48 one month after the date of grant and 1/48th each month thereafter. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 16:46 UTC |
Ladd Amy LDirector
|
GrantRestricted Stock Units · Derivative | 183 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001035267-19-000112 · edgardoc.xml · derivative · entry 2 Ladd Amy L · CIK 0001781750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183 Underlying: Common Stock · 183 shares Expires 2020-08-03 F1 · derivative.exercise_date: 100% of the grant will vest on the anniversary date of the grant or the next Annual Shareholders Meeting, whichever takes place first, provided however that vesting will cease on termination of the Director's service to the company. Read SEC document |
| August 02, 2019 Filed Aug 6, 2019 16:46 UTC |
Ladd Amy LDirector
|
GrantNon-Qualified Stock Option (right to buy) · Derivative | 550 | $0.00 Strike: $513.60 | $0.00 |
DisclosureSEC source: 0001035267-19-000112 · edgardoc.xml · derivative · entry 1 Ladd Amy L · CIK 0001781750 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550 Underlying: Common Stock · 550 shares Expires 2029-08-02 F1 · derivative.exercise_date: 100% of the grant will vest on the anniversary date of the grant or the next Annual Shareholders Meeting, whichever takes place first, provided however that vesting will cease on termination of the Director's service to the company. Read SEC document |
| July 31, 2019 Filed Aug 1, 2019 20:46 UTC |
KANIA DON RDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 215 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-015615 · doc1.xml · derivative · entry 2 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 215 shares Expires 2019-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Restricted Stock Units (RSUs) are granted pursuant to the 2010 Incentive Award Plan. The RSUs fully vest on the first anniversary of the date of grant. Read SEC document |
| July 31, 2019 Filed Aug 1, 2019 20:46 UTC |
KANIA DON RDirector
|
Exercise / conversionCommon Stock | 215 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-015615 · doc1.xml · nonDerivative · entry 1 KANIA DON R · CIK 0001254028 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 22:38 UTC |
MOHR MARSHALLExecutive VP & CFO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $113.73 | $0.00 |
DisclosureSEC source: 0001035267-19-000109 · edgardoc.xml · derivative · entry 7 MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 7,500 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The trades are in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 14, 2019. F5 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 1/8 six months after the date of grant and 1/48th each month thereafter. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 22:38 UTC |
MOHR MARSHALLExecutive VP & CFO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,500 | $0.00 Strike: $113.73 | $0.00 |
DisclosureSEC source: 0001035267-19-000109 · edgardoc.xml · derivative · entry 6 MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,500 Underlying: Common Stock · 7,500 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The trades are in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 14, 2019. F5 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 1/8 six months after the date of grant and 1/48th each month thereafter. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 22:38 UTC |
MOHR MARSHALLExecutive VP & CFO
|
SaleCommon Stock | 7,500 | $526.09 | $3,945,640.50 |
DisclosureSEC source: 0001035267-19-000109 · edgardoc.xml · nonDerivative · entry 4 MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,635 F1 · kind: The trades are in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 14, 2019. F3 · price: The average selling price for the transactions was $526.0853 The shares sold at: $523.00 - $523.99 = 670 shares; $524.00 - $524.99 = 1,150 shares; $525.00 - $525.99 = 1,081 shares; $526.00 to $526.99 = 2,538 shares; $527.00 - $527.99 = 1,560 shares; and $528.00 - $528.99 = 501 shares. F4 · balance_after: The Reporting Person's Form 4 filed with the SEC on February 21, 2019 inadvertently overstated the amount of securities beneficially owned following the reported transaction by 78 shares in Column 5 of Table I. This Form 4 reflects an adjustment to Column 5 total to correct the aforementioned error. Except as otherwise noted in this footnote, all other information disclosed in the Reporting Person's original Form 4 was accurately reported. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 22:38 UTC |
MOHR MARSHALLExecutive VP & CFO
|
Exercise / conversionCommon Stock | 7,500 | $113.73 | $852,975.00 |
DisclosureSEC source: 0001035267-19-000109 · edgardoc.xml · nonDerivative · entry 3 MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,135 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The trades are in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 14, 2019. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 22:38 UTC |
MOHR MARSHALLExecutive VP & CFO
|
SaleCommon Stock | 7,500 | $526.14 | $3,946,052.25 |
DisclosureSEC source: 0001035267-19-000109 · edgardoc.xml · nonDerivative · entry 2 MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,635 F1 · kind: The trades are in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 14, 2019. F2 · price: The average selling price for the transactions was $526.1403 The shares sold at: $523.00 - $523.99 = 600 shares; $524.00 - $524.99 = 1,176 shares; $525.00 - $525.99 = 1,265 shares; $526.00 to $526.99 = 2,063 shares; $527.00 - $527.99 = 1,560 shares; and $528.00 - $528.99 = 836 shares. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 22:38 UTC |
MOHR MARSHALLExecutive VP & CFO
|
Exercise / conversionCommon Stock | 7,500 | $113.73 | $852,975.00 |
DisclosureSEC source: 0001035267-19-000109 · edgardoc.xml · nonDerivative · entry 1 MOHR MARSHALL · CIK 0001252986 · Executive VP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,135 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The trades are in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 14, 2019. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 01:05 UTC |
Andersen Reiter KaraSr VP General Counsel & CCO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $170.76 | $0.00 |
DisclosureSEC source: 0001035267-19-000104 · edgardoc.xml · derivative · entry 4 Andersen Reiter Kara · CIK 0001766950 · Sr VP General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 3,000 shares Expires 2025-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on March 16, 2020 F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 01:05 UTC |
Andersen Reiter KaraSr VP General Counsel & CCO
|
SaleCommon Stock | 1,120 | $540.00 | $604,800.00 |
DisclosureSEC source: 0001035267-19-000104 · edgardoc.xml · nonDerivative · entry 3 Andersen Reiter Kara · CIK 0001766950 · Sr VP General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,718 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on March 16, 2020 Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 01:05 UTC |
Andersen Reiter KaraSr VP General Counsel & CCO
|
SaleCommon Stock | 3,000 | $540.00 | $1,620,000.00 |
DisclosureSEC source: 0001035267-19-000104 · edgardoc.xml · nonDerivative · entry 2 Andersen Reiter Kara · CIK 0001766950 · Sr VP General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,838 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on March 16, 2020 Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 01:05 UTC |
Andersen Reiter KaraSr VP General Counsel & CCO
|
Exercise / conversionCommon Stock | 3,000 | $170.76 | $512,270.10 |
DisclosureSEC source: 0001035267-19-000104 · edgardoc.xml · nonDerivative · entry 1 Andersen Reiter Kara · CIK 0001766950 · Sr VP General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on March 16, 2020 Read SEC document |
| July 24, 2019 Filed Jul 30, 2019 21:53 UTC Amendment |
Andersen Reiter KaraSr VP General Counsel & CCO
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $170.76 | $0.00 |
DisclosureSEC source: 0001567619-19-015467 · doc1.xml · derivative · entry 4 Andersen Reiter Kara · CIK 0001766950 · Sr VP General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 3,000 shares Expires 2025-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on March 16, 2020. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. F3 · balance_after: The Reporting Person's Form 4 filed with the SEC on 07/24/2019 inadvertently omitted the Power of Attorney as an exhibit. The transactions reported in this Form 4/A are being re-reported solely to allow the filing of this amendment to attach the Power of Attorney. Except as otherwise noted in this footnote, all other information disclosed in the Reporting Person's original Form 4 was accurately reported. Read SEC document |
| July 24, 2019 Filed Jul 30, 2019 21:53 UTC Amendment |
Andersen Reiter KaraSr VP General Counsel & CCO
|
SaleCommon Stock | 1,120 | $540.00 | $604,800.00 |
DisclosureSEC source: 0001567619-19-015467 · doc1.xml · nonDerivative · entry 3 Andersen Reiter Kara · CIK 0001766950 · Sr VP General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,718 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on March 16, 2020. F3 · balance_after: The Reporting Person's Form 4 filed with the SEC on 07/24/2019 inadvertently omitted the Power of Attorney as an exhibit. The transactions reported in this Form 4/A are being re-reported solely to allow the filing of this amendment to attach the Power of Attorney. Except as otherwise noted in this footnote, all other information disclosed in the Reporting Person's original Form 4 was accurately reported. Read SEC document |
| July 24, 2019 Filed Jul 30, 2019 21:53 UTC Amendment |
Andersen Reiter KaraSr VP General Counsel & CCO
|
SaleCommon Stock | 3,000 | $540.00 | $1,620,000.00 |
DisclosureSEC source: 0001567619-19-015467 · doc1.xml · nonDerivative · entry 2 Andersen Reiter Kara · CIK 0001766950 · Sr VP General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,838 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on March 16, 2020. F3 · balance_after: The Reporting Person's Form 4 filed with the SEC on 07/24/2019 inadvertently omitted the Power of Attorney as an exhibit. The transactions reported in this Form 4/A are being re-reported solely to allow the filing of this amendment to attach the Power of Attorney. Except as otherwise noted in this footnote, all other information disclosed in the Reporting Person's original Form 4 was accurately reported. Read SEC document |
| July 24, 2019 Filed Jul 30, 2019 21:53 UTC Amendment |
Andersen Reiter KaraSr VP General Counsel & CCO
|
Exercise / conversionCommon Stock | 3,000 | $170.76 | $512,270.10 |
DisclosureSEC source: 0001567619-19-015467 · doc1.xml · nonDerivative · entry 1 Andersen Reiter Kara · CIK 0001766950 · Sr VP General Counsel & CCO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on March 16, 2020. F3 · balance_after: The Reporting Person's Form 4 filed with the SEC on 07/24/2019 inadvertently omitted the Power of Attorney as an exhibit. The transactions reported in this Form 4/A are being re-reported solely to allow the filing of this amendment to attach the Power of Attorney. Except as otherwise noted in this footnote, all other information disclosed in the Reporting Person's original Form 4 was accurately reported. Read SEC document |
| July 23, 2019 Filed Jul 23, 2019 21:39 UTC |
Samath JamieVP & Principal Accounting Offi
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 118 | $0.00 Strike: $238.91 | $0.00 |
DisclosureSEC source: 0001035267-19-000093 · edgardoc.xml · derivative · entry 9 Samath Jamie · CIK 0001330269 · VP & Principal Accounting Offi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,129 Underlying: Common Stock · 118 shares Expires 2027-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 4, 2019. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 23, 2019 Filed Jul 23, 2019 21:39 UTC |
Samath JamieVP & Principal Accounting Offi
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 70 | $0.00 Strike: $231.00 | $0.00 |
DisclosureSEC source: 0001035267-19-000093 · edgardoc.xml · derivative · entry 8 Samath Jamie · CIK 0001330269 · VP & Principal Accounting Offi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247 Underlying: Common Stock · 70 shares Expires 2026-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 4, 2019. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. Option shall vest 7/48 one month after the date of grant and 1/48th each month thereafter. Read SEC document |
| July 23, 2019 Filed Jul 23, 2019 21:39 UTC |
Samath JamieVP & Principal Accounting Offi
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 71 | $0.00 Strike: $178.39 | $0.00 |
DisclosureSEC source: 0001035267-19-000093 · edgardoc.xml · derivative · entry 7 Samath Jamie · CIK 0001330269 · VP & Principal Accounting Offi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245 Underlying: Common Stock · 71 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 4, 2019. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 23, 2019 Filed Jul 23, 2019 21:39 UTC |
Samath JamieVP & Principal Accounting Offi
|
SaleCommon Stock | 71 | $532.14 | $37,781.94 |
DisclosureSEC source: 0001035267-19-000093 · edgardoc.xml · nonDerivative · entry 6 Samath Jamie · CIK 0001330269 · VP & Principal Accounting Offi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 4, 2019. Read SEC document |
| July 23, 2019 Filed Jul 23, 2019 21:39 UTC |
Samath JamieVP & Principal Accounting Offi
|
Exercise / conversionCommon Stock | 71 | $178.39 | $12,665.46 |
DisclosureSEC source: 0001035267-19-000093 · edgardoc.xml · nonDerivative · entry 5 Samath Jamie · CIK 0001330269 · VP & Principal Accounting Offi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 4, 2019. Read SEC document |
| July 23, 2019 Filed Jul 23, 2019 21:39 UTC |
Samath JamieVP & Principal Accounting Offi
|
SaleCommon Stock | 70 | $532.14 | $37,249.80 |
DisclosureSEC source: 0001035267-19-000093 · edgardoc.xml · nonDerivative · entry 4 Samath Jamie · CIK 0001330269 · VP & Principal Accounting Offi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 4, 2019. Read SEC document |
| July 23, 2019 Filed Jul 23, 2019 21:39 UTC |
Samath JamieVP & Principal Accounting Offi
|
Exercise / conversionCommon Stock | 70 | $231.00 | $16,169.77 |
DisclosureSEC source: 0001035267-19-000093 · edgardoc.xml · nonDerivative · entry 3 Samath Jamie · CIK 0001330269 · VP & Principal Accounting Offi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 4, 2019. Read SEC document |
| July 23, 2019 Filed Jul 23, 2019 21:39 UTC |
Samath JamieVP & Principal Accounting Offi
|
SaleCommon Stock | 118 | $532.14 | $62,792.52 |
DisclosureSEC source: 0001035267-19-000093 · edgardoc.xml · nonDerivative · entry 2 Samath Jamie · CIK 0001330269 · VP & Principal Accounting Offi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 4, 2019. Read SEC document |
| July 23, 2019 Filed Jul 23, 2019 21:39 UTC |
Samath JamieVP & Principal Accounting Offi
|
Exercise / conversionCommon Stock | 118 | $238.91 | $28,191.77 |
DisclosureSEC source: 0001035267-19-000093 · edgardoc.xml · nonDerivative · entry 1 Samath Jamie · CIK 0001330269 · VP & Principal Accounting Offi 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 4, 2019. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 750 | $0.00 Strike: $238.91 | $0.00 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · derivative · entry 18 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,250 Underlying: Common Stock · 750 shares Expires 2027-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 750 | $0.00 Strike: $231.00 | $0.00 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · derivative · entry 17 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Common Stock · 750 shares Expires 2026-08-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. Option shall vest 7/48 one month after the date of grant and 1/48th each month thereafter. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $189.74 | $0.00 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · derivative · entry 16 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,950 Underlying: Common Stock · 1,500 shares Expires 2023-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 750 | $0.00 Strike: $178.39 | $0.00 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · derivative · entry 15 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 437 Underlying: Common Stock · 750 shares Expires 2026-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 611 | $0.00 Strike: $177.68 | $0.00 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · derivative · entry 14 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 611 shares Expires 2025-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. F3 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. Option shall vest 7/48 one month after the date of grant and 1/48th each month thereafter. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 613 | $0.00 Strike: $171.33 | $0.00 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · derivative · entry 13 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 613 shares Expires 2025-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. F2 · derivative.exercise_date: Non-statutory stock option granted pursuant to the 2010 Employee Stock Option Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 1,500 | $532.14 | $798,210.00 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · nonDerivative · entry 12 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,101 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 1,500 | $189.74 | $284,605.05 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · nonDerivative · entry 11 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 613 | $532.14 | $326,201.82 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · nonDerivative · entry 10 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,101 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 613 | $171.33 | $105,027.31 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · nonDerivative · entry 9 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 611 | $532.14 | $325,137.54 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · nonDerivative · entry 8 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,101 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 611 | $177.68 | $108,564.50 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · nonDerivative · entry 7 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 750 | $532.14 | $399,105.00 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · nonDerivative · entry 6 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,101 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 750 | $178.39 | $133,790.03 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · nonDerivative · entry 5 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 750 | $532.14 | $399,105.00 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · nonDerivative · entry 4 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,101 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 750 | $231.00 | $173,247.53 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · nonDerivative · entry 3 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
SaleCommon Stock | 750 | $532.14 | $399,105.00 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · nonDerivative · entry 2 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,101 F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. Read SEC document |
| July 23, 2019 Filed Jul 25, 2019 16:38 UTC |
Curet MyriamEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 750 | $238.91 | $179,184.98 |
DisclosureSEC source: 0001035267-19-000100 · edgardoc.xml · nonDerivative · entry 1 Myriam Curet · CIK 0001632901 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,851 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on June 15, 2020. Read SEC document |
| July 23, 2019 Filed Aug 20, 2019 18:35 UTC |
SMITH LONNIE MDirector
|
GiftCommon Stock | 14,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-19-000130 · edgardoc.xml · nonDerivative · entry 9 SMITH LONNIE M · CIK 0001238937 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 261,819 F3 · kind: Shares were distributed by The Trust Company of Oxford, TR U/A 5/29/18 Lonnie M. Smith GRAT 13, to Lonnie Smith & Cheryl Smith, Community Property. Read SEC document |
| July 23, 2019 Filed Aug 20, 2019 18:35 UTC |
SMITH LONNIE MDirector
|
GiftCommon Stock | 7,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001035267-19-000130 · edgardoc.xml · nonDerivative · entry 8 SMITH LONNIE M · CIK 0001238937 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 275,819 F6 · kind: Shares were distributed by Lonnie M. Smith Heartflow GRAT UA 12/05/2012 to Lonnie Smith & Cheryl Smith, Community Property. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.